Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has closed and adds several help/navigation items, along with a label formatting change for Intervention/Treatment and an update from revision v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:15:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The revision history shows the page updated from v3.5.4 to v3.5.5, indicating a minor metadata update to the ClinicalTrials.gov record.
    Difference
    0.0%
    Check dated 2026-06-08T03:49:23.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the page metadata. No study content or user-facing features are indicated to be affected by this update.
    Difference
    0.0%
    Check dated 2026-05-17T09:38:37.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site software/document rendering version rather than the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T18:41:06.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:29:07.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Added the term 'Small cell lung carcinoma' in the related terms and a link to the Genetic and Rare Diseases Information Center in the Resources section.
    Difference
    0.1%
    Check dated 2026-03-28T03:15:11.000Z thumbnail image

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.